Literature DB >> 22233113

Clarithromycin potentiates tyrosine kinase inhibitor treatment in patients with resistant chronic myeloid leukemia.

Angelo Michele Carella, Germana Beltrami, Gianmatteo Pica, Andrea Carella, Gioacchino Catania.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22233113     DOI： 10.3109/10428194.2012.656105

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  10 in total

Review 1.  Targeting survival pathways in chronic myeloid leukaemia stem cells.

Authors:  A Sinclair; A L Latif; T L Holyoake
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

Review 2.  Drug repurposing in oncology--patient and health systems opportunities.

Authors:  Francesco Bertolini; Vikas P Sukhatme; Gauthier Bouche
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

Review 3.  Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond.

Authors:  Wesam Ahmed; Richard A Van Etten
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

Review 4.  Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing.

Authors:  Talal El Zarif; Marcel Yibirin; Diana De Oliveira-Gomes; Marc Machaalani; Rashad Nawfal; Gianfranco Bittar; Hisham F Bahmad; Nizar Bitar
Journal:  Cancers (Basel)       Date:  2022-04-23       Impact factor: 6.575

Review 5.  Autophagy in chronic myeloid leukaemia: stem cell survival and implication in therapy.

Authors:  Gudmundur V Helgason; Arunima Mukhopadhyay; Maria Karvela; Paolo Salomoni; Bruno Calabretta; Tessa L Holyoake
Journal:  Curr Cancer Drug Targets       Date:  2013-09       Impact factor: 3.428

Review 6.  Autophagy in blood cancers: biological role and therapeutic implications.

Authors:  Alessio Nencioni; Michele Cea; Fabrizio Montecucco; Valter D Longo; Franco Patrone; Angelo M Carella; Tessa L Holyoake; G Vignir Helgason
Journal:  Haematologica       Date:  2013-09       Impact factor: 9.941

7.  What challenges remain in chronic myeloid leukemia research?

Authors:  Angelo M Carella; Susan Branford; Michael Deininger; Francois X Mahon; Giuseppe Saglio; Anna Eiring; Jamshid Khorashad; Thomas O'Hare; John M Goldman
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

8.  Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells.

Authors:  Shota Moriya; Xiao-Fang Che; Seiichiro Komatsu; Akihisa Abe; Tomohiro Kawaguchi; Akihiko Gotoh; Masato Inazu; Akio Tomoda; Keisuke Miyazawa
Journal:  Int J Oncol       Date:  2013-03-28       Impact factor: 5.650

9.  Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent.

Authors:  An Mt Van Nuffel; Vidula Sukhatme; Pan Pantziarka; Lydie Meheus; Vikas P Sukhatme; Gauthier Bouche
Journal:  Ecancermedicalscience       Date:  2015-02-24

10.  Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels.

Authors:  S Pillozzi; M Masselli; L Gasparoli; M D'Amico; L Polletta; M Veltroni; C Favre; G Basso; A Becchetti; A Arcangeli
Journal:  Blood Cancer J       Date:  2016-05-13       Impact factor: 11.037
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.